{"filing":{"accession_number":"0001628280-26-054353","cik":"0001237831","ticker":"GMED","company_name":"GLOBUS MEDICAL INC","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"gmed-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1237831/000162828026054353/gmed-20260806.htm"},"events":[{"id":25913,"run_id":23528,"accession_number":"0001628280-26-054353","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Globus Medical issued a press release on August 6, 2026 reporting its sales and operating results for the three and six month periods ended June 30, 2026. The disclosure includes net sales of $789.6 million (5.9% increase), GAAP net income of $151.6 million, GAAP diluted EPS of $1.10, and non-GAAP diluted EPS of $1.34 (55.8% increase), along with updated 2026 guidance for non-GAAP fully diluted EPS. This is a standard quarterly earnings release with consolidated financial statements and management commentary, clearly falling under Item 2.02 Results of Operations and Financial Condition.","company_name":"GLOBUS MEDICAL INC","ticker":"GMED","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26852,"accession_number":"0001628280-26-054353","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Globus Medical issued a press release on August 6, 2026 reporting its sales and operating results for the three and six month periods ended June 30, 2026. The disclosure includes net sales of $789.6 million (5.9% increase), GAAP net income of $151.6 million, GAAP diluted EPS of $1.10, and non-GAAP diluted EPS of $1.34 (55.8% increase), along with updated 2026 guidance for non-GAAP fully diluted EPS. This is a standard quarterly earnings release with consolidated financial statements and management commentary, clearly falling under Item 2.02 Results of Operations and Financial Condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:46:23.973586+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26852,"accession_number":"0001628280-26-054353","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Globus Medical issued a press release on August 6, 2026 reporting its sales and operating results for the three and six month periods ended June 30, 2026. The disclosure includes net sales of $789.6 million (5.9% increase), GAAP net income of $151.6 million, GAAP diluted EPS of $1.10, and non-GAAP diluted EPS of $1.34 (55.8% increase), along with updated 2026 guidance for non-GAAP fully diluted EPS. This is a standard quarterly earnings release with consolidated financial statements and management commentary, clearly falling under Item 2.02 Results of Operations and Financial Condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:46:23.973586+00:00","company_name":"GLOBUS MEDICAL INC","ticker":"GMED","filing_date":"2026-08-06"}]}